Khartis Therapeutics, Inc.

Khartis Therapeutics is a San Diego-based biotechnology company focused on the discovery and development of novel oral small molecule therapies for patients with immune-mediated and chronic inflammatory diseases. The company leverages translational research and scientific innovation to create impactful treatments for significant unmet medical needs in the immunology space. The company was founded by a team of experienced drug hunters with a track record of success at major pharmaceutical firms and high-growth biotechs. Khartis aims to transition from traditional broad immunosuppression toward more targeted, precision-based oral therapies that offer improved safety and efficacy profiles for chronic conditions.